A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Registry ID

EUCTR2008-008974-30

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE3

Sponsor

Phenomix Corporation

Start date

2009-09-08

Completion date

2010-06-25

Last update

2026-08-16

Conditions

• Type II Diabetes Mellitus

Summary

To demonstrate the efficacy of dutogliptin over 26 weeks, as evidenced by placebo-corrected changes in HbA1c

Locations

• , , Czechia

Related clinical trials

• The GRoceries Aimed at Increasing Nutrition Study
• A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
• cfMSC Therapy for Diabetes
• Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
• Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

View on source registry